Your browser doesn't support javascript.
loading
Human epidermal growth factor 2 (HER2) in early stage uterine serous carcinoma: A multi-institutional cohort study.
Erickson, Britt K; Najjar, Omar; Damast, Shari; Blakaj, Adriana; Tymon-Rosario, Joan; Shahi, Maryam; Santin, Alessandro; Klein, Molly; Dolan, Michelle; Cimino-Mathews, Ashley; Buza, Natalia; Ferriss, J Stuart; Stone, Rebecca L; Khalifa, Mahmoud; Fader, Amanda N.
Afiliación
  • Erickson BK; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology University of Minnesota, Minneapolis, MN, USA. Electronic address: bkeric@umn.edu.
  • Najjar O; Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Damast S; Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT, USA.
  • Blakaj A; Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT, USA.
  • Tymon-Rosario J; Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, New Haven, CT, USA.
  • Shahi M; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Santin A; Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, New Haven, CT, USA.
  • Klein M; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.
  • Dolan M; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.
  • Cimino-Mathews A; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Buza N; Department of Pathology, Yale School of Medicine, New Haven, CT, USA.
  • Ferriss JS; Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Stone RL; Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Khalifa M; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.
  • Fader AN; Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Gynecol Oncol ; 159(1): 17-22, 2020 10.
Article en En | MEDLINE | ID: mdl-32709539
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Uterinas / Biomarcadores de Tumor / Cistadenocarcinoma Seroso / Receptor ErbB-2 / Recurrencia Local de Neoplasia Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Gynecol Oncol Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Uterinas / Biomarcadores de Tumor / Cistadenocarcinoma Seroso / Receptor ErbB-2 / Recurrencia Local de Neoplasia Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Gynecol Oncol Año: 2020 Tipo del documento: Article